← Leaderboards
Alex Lyubimov
University Of Illinois At Urbana-Champaign
$714,558
Attributed
$714,558
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$714,558 · 1
By mechanism
N03$714,558 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Urbana-Champaign
Same institution · by research overlap
- Jodi A Flaws$22,576,376
- Romana A Nowak$7,575,214
- Timothy M Fan$2,335,730
- Paul R Selvin$15,958,940
- Shiva Abbaszadeh$4,205,032
Others in their field
Top investigators on “Cancer Patient”
- David Heimbrook · Leidos Biomedical Research, Inc.$436,176,488
- Larry Arthur$370,429,903
- Norman Wolmark · Nsabp Foundation, Inc.$324,028,859
- Gregory H Reaman · National Childhood Cancer Foundation$270,366,096
- Leonard Freedman · Leidos Biomedical Research, Inc.$268,085,841
- Richard A Gibbs · Baylor College Of Medicine$240,560,484
Research focus
Cancer PatientPharmaceutical PreparationsAwardCanis FamiliarisChargeContractsDna Modification MethylasesInvestigationMalignant NeoplasmsMeetingsOrganRattusResearch Clinical TestingToxic EffectAnticancer ActivityToxicologyAnti-Cancer Therapeutic
Grant awards (2)
IGF::OT::IGF NEXT - DNA METHYLTRANSFERASE-TDCYD TO#3 CONDUCT STUDIES $234,760 RAT (NX157-110-187-003) & $478,298 DOG (NX157-110-187-004) PRE-CLIN TOX STUDY OF DRUG DEV FOR CANCER PATIENTS HHSN26120160$713,058
N03 · FY2016 · CA · contact PI
IGF::OT::IGF INITIAL ADMINISTRATIVE CHARGES TO#1 PRE-CLIN TOX STUDY OF DRUG DEV FOR CANCER PATIENTS HHSN261201600019I DTP-16-044 TPB$1,500
N03 · FY2016 · CA · contact PI